bioAffinity Technologies, Inc. Common Stock Profile
About
bioAffinity Technologies Inc. is a cancer diagnostics company which develops noninvasive, early-stage diagnostics to detect cancer and diseases of the lung and is researching targeted therapies to treat cancer. bioAffinity Technologies Inc. is based in SAN ANTONIO.
Info & Links
CEO
Maria Zannes
Headquarters
3300 NACOGDOCHES ROAD, SUITE 216 SAN ANTONIO, TX 78217, UNITED STATES
bioAffinity Technologies, Inc. Common Stock Statistics
Valuation Measures
Market Capitalization2
12.83M
Enterprise Value
12.76M
Enterprise Value/EBITDA(ttm)
-1.53
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
1.35
Price to Book(mrq)
3.49
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
35.97%
Operating Margin(ttm)
-91.22%
Profit Margin(ttm)
-97.27%
Return on Equity(ttm)
-205.09%
Return on Invested Capital(ttm)
-235.13%
Return on Assets(ttm)
-115.95%
Income Statement
Revenue(ttm)
9.36M
Revenue Per Share(ttm)
0.51
Gross Profit(ttm)
3.38M
EBITDA(ttm)3
-8.35M
Net Income Available to Common(ttm)
-9.04M
Diluted EPS(ttm)
-0.82
Share Statistics
Beta (5Y Monthly)
2.95
52-Week Change
-66.51%
S&P 500 52-Week Change
3.55%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
18.26M
Dividend Yield
0.00%
Float4
10.11M
% Held by Insiders
35.12%
% Held by Institutions
1.64%
Balance Sheet
Total Cash(mrq)
1.11M
Total Cash Per Share(mrq)
0.06
Total Debt(mrq)
1.03M
Total Debt/Equity(mrq)
39.65%
Current Ratio(mrq)
0.87%
Quick Ratio(mrq)
1.01%
Book Value Per Share(mrq)
0.17
Cash Flow
Operating Cash Flow Per Share(ytd)
-0.60
Free Cash Flow(ytd)
-7.34M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.